Globotriaosylceramide-induced reduction of KCa1.1 channel activity and activation of the Notch1 signaling pathway in skin fibroblasts of male Fabry patients with pain
Authors:
Open Access
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 324, 113134
Abstract
No abstract availableKeywords
Funding Information
- Julius-Maximilians-Universität Würzburg (UE171-5/1)
- Sanofi Genzyme
- Deutsche Forschungsgemeinschaft (DFG UE171-6/1)
This publication has 45 references indexed in Scilit:
- The spinal notch signaling pathway plays a pivotal role in the development of neuropathic painMolecular Brain, 2012
- Nociceptors: the sensors of the pain pathwayJournal of Clinical Investigation, 2010
- Ca2+-Activated K+Channels: From Protein Complexes to FunctionPhysiological Reviews, 2010
- Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome SurveyJournal of Medical Genetics, 2009
- Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapyNephrology Dialysis Transplantation, 2009
- Ca2+-Activated K+ Channels in Gonadotropin-Releasing Hormone-Stimulated Mouse GonadotrophsEndocrinology, 2008
- Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cellsMolecular Genetics and Metabolism, 2008
- The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathologyBrain, 2008
- High-conductance potassium channels of the SLO familyNature Reviews Neuroscience, 2006
- Topographically Distinct Epidermal Nociceptive Circuits Revealed by Axonal Tracers Targeted to MrgprdNeuron, 2005